Cell senescence and hypermitogenic arrest
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
A diverse range of conditions, from mitogenic stimuli to cytotoxic stress, can induce cell senescence. Here, I propose that simultaneous stimulation of mitogen-activated pathways and downstream inhibition of cyclin-dependent kinases leads, ultimately, to cell senescence. This model distinguishes between two types of growth arrest: first, exit to G0 phase, which is caused by the withdrawal of mitogens and can lead to apoptosis; and second, hypermitogenic arrest, which is stimulated by mitogens and can lead to senescence. The concept of hypermitogenic arrest defines cell senescence as a functionally active, stable and conditionally reversible state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 3×
“Furthermore, both p21 and p27 can have opposing effects on CDK4/6 and CDK2 (Sherr & Roberts, 1999).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“In primary cells, Ras and the downstream MAPK pathways can induce senescence due to the induction of CDKIs (Missero et al., 1996; Serrano et al., 1997; Lin et al., 1998; Zhu”
BackgroundMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906 · cited 10×
“For example, DNA-damaging agents cause the induction of CDKIs (such as p21) and changes in the phosphorylation states of CDKs and, thereby, their inhibition.”
BackgroundInfluentialTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“Finally, oncogenes that act downstream of the restriction point (such as c-Myc and CDK4), and thus may overcome senescence, cooperate with hypermitogenic oncogenes (such as Ras), leading to malignant transformation (Land et al., 1983).”
BackgroundSocial controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604 · cited 2×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
BackgroundA Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523 · cited 3×
“Senescence may result from telomere shortening, which occurs during each cell cycle in some cell types, but senescence does not occur in others unless they are cultured under inadequate conditions (Mathon et al., 2001; Tang et al., 2001).”
BackgroundA Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415 · cited 1×
“This point in late G1 phase is known as the ‘restriction point’ (Pardee, 1974).”
BackgroundLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · cited 3×
“Upstream and downstream signalling It is assumed that cellular senescence evolved to suppress tumorigenesis (Lin et al., 1998; Campisi, 2001); that is, normal cells can”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Cited by
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
“Cellular senescence can also be induced by strong, chronic, or unbalanced mitogenic signals (44) (Figure 1), consistent with its role in suppressing tumorigenesis.”
BackgroundTGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
“Strong mitogenic activators such as activated Ras or growth factor receptor activation can provoke a shut down in the cell cycle with induction of senescence (Blagosklonny 2003; Senturk et al. 2010).”
BackgroundRapamycin decelerates cellular senescence
Demidenko, Z. N., Zubova, S. G., Bukreeva, E. I., Pospelov, V. A., Pospelova, T. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8606 · Cited by 391
Self-citationTai, H., Wang, Z., Gong, H., Han, X., Zhou, J., Wang, X., Wei, X., Ding, Y., Huang, N., Qin, J., et al. (2017) · Autophagy · doi:10.1080/15548627.2016.1247143 · Cited by 334
Han, X., Tai, H., Wang, X., Wang, Z., Zhou, J., Wei, X., Ding, Y., Gong, H., Mo, C., Zhang, J., et al. (2016) · Aging Cell · doi:10.1111/acel.12446 · Cited by 302
“associated with progressing cellular senescence that featured as the growth arrest, impaired function, and declined metabolism (Toussaint et al., 2000; Blagosklonny, 2003).”
BackgroundApoptosis and genomic instability
Zhivotovsky, B., & Kroemer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1443 · Cited by 299
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100443 · Cited by 251
“From theoretical perspective, hypertrophy will eventually be limited by activation of lysosomes/autophagy [7].”
BackgroundSelf-citationFu, Y., Hsieh, T.-C., Guo, J., Kunicki, J., Lee, M. Y. W. T., Darzynkiewicz, Z., & Wu, J. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.094 · Cited by 245
Cell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
“In theory [3,4], over-activated growth-promoting pathway, when the cell cycle is blocked downstream, must lead to cellular hypertrophy (a large cell morphology), pro-inflammatory and hyper-secretory phenotypes, cellular overactivation with a feedback signal-resistance and a compensatory deactivation of some signaling…”
BackgroundSelf-citationRapamycin for longevity: opinion article
Blagosklonny, M. V. (2019) · Aging · doi:10.18632/aging.102355 · Cited by 205
“It was predicted in 2003[146] that conversion from quiescence to senescence (geroconversion) is driven by growthpromoting mediators, such as mTOR, when the cell cycle is blocked [147].”
BackgroundSelf-citationAnswering the ultimate question “What is the Proximal Cause of Aging?”
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100525 · Cited by 190
“The senescence-associated secretory phenotype (SASP) [6973] is a characteristic hyperfunction of fibroblasts (and some other cells) caused by hyper-mitogenic stimulation of arrested cells [74, 35].”
BackgroundSelf-citationAlimbetov, D., Davis, T., Brook, A. J. C., Cox, L. S., Faragher, R. G. A., Nurgozhin, T., Zhumadilov, Z., & Kipling, D. (2016) · Biogerontology · doi:10.1007/s10522-015-9610-z · Cited by 162
“Several experimental manipulations such as hyperoxia, hypermitogenic signalling or oncogene expression can also trigger entry into a senescence-like state (Blagosklonny 2003; Saretzki and Von Zglinicki 2002; Shay and Roninson 2004).”
BackgroundLeontieva, O. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100265 · Cited by 160
“In theory, if the cell cycle is blocked, while serum continues to activate GF-sensing pathways, cells will senesce [16, 17].”
BackgroundSelf-citationLeontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405723111 · Cited by 149
“Aging (Albany, NY Online) 4(3):159–165.”
Self-citationCellular Senescence as the Causal Nexus of Aging
Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 146
“Similar to inflammation, chronic mitogenic signals are another mechanism known to induce cellular senescence (Blagosklonny, 2003).”
BackgroundAging is not programmed: Genetic pseudo-program is a shadow of developmental growth
Blagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.27188 · Cited by 143
“Furthermore, the same signaling pathways drive cellular geroconversion: a conversion from cellular quiescence to senescence.(19-40) The same PI3K/TOR pathway is also involved in cancer and other age-related diseases.”
BackgroundSelf-citationXu, Z., Feng, W., Shen, Q., Yu, N., Yu, K., Wang, S., Chen, Z., Shioda, S., & Guo, Y. (2017) · Aging and disease · doi:10.14336/ad.2016.0620 · Cited by 142
Geroconversion: irreversible step to cellular senescence
Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985507 · Cited by 138
“(In contrast, in quiescence the motor is off: normal parking).(40) Activation of mTOR, when the cell cycle is blocked, leads to senescent morphology, including loss of the ability to re-start proliferation.”
BackgroundSelf-citationNew Insights into CDK Regulators: Novel Opportunities for Cancer Therapy
Bury, M., Calvé, B. L., Ferbeyre, G., Blank, V., & Lessard, F. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.01.010 · Cited by 144
The hyperfunction theory: An emerging paradigm for the biology of aging
Gems, D. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101557 · Cited by 125
“Key to the initial development of Blagosklonny’s theorem was his realization that growth stimulation leads rapidly to cellular senescence when the cell cycle is arrested, with no involvement of molecular damage (Blagosklonny, 2003a).”
From causes of aging to death from COVID-19
Blagosklonny, M. V. (2020) · Aging · doi:10.18632/aging.103493 · Cited by 124
“, p21 and p16), then growth-promoting pathways such as mTOR and MAPK drive conversion to senescence (geroconversion) [24, 74, 75].”
BackgroundSelf-citationCell fate determination during G1 phase progression
Blomen, V. A., & Boonstra, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7271-z · Cited by 140
Cellular Senescence - its role in cancer and the response to ionizing radiation
Sabin, R. J., & Anderson, R. M. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-7 · Cited by 113
“leads to the inhibition of cyclin-dependant kinases [7,8].”
BackgroundVitiligo: A Possible Model of Degenerative Diseases
Bellei, B., Pitisci, A., Ottaviani, M., Ludovici, M., Cota, C., Luzi, F., Dell’Anna, M. L., & Picardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059782 · Cited by 112
Rapamycin and quasi-programmed aging: Four years later
Blagosklonny, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11872 · Cited by 100
“To be tested: stimulation of growth-promoting pathways, when the cell cycle is blocked and cells cannot grow, causes cellular senescence.(15) This prediction was confirmed.”
BackgroundSelf-citationSaab, R. H., Bills, J. L., Miceli, A. P., Anderson, C., Khoury, J. D., Fry, D. W., Navid, F., Houghton, P. J., & Skapek, S. X. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0383 · Cited by 96
“cell differentiation or senescence (58).”
Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis
Carroll, B., Korolchuk, V. I., & Sarkar, S. (2014) · Amino Acids · doi:10.1007/s00726-014-1775-2 · Cited by 110
“The current working hypothesis is that induction of senescence occurs through a hyperactive growth mechanism involving overactive or ectopic mTORC1 activity (Blagosklonny 2003, 2008).”
BackgroundCell senescence: Hypertrophic arrest beyond the restriction point
Blagosklonny, M. V. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20750 · Cited by 93
“In agreement, T-antigen and E1A, acting downstream from R-point, abrogate such a ‘‘terminal’’ arrest (Blagosklonny, 2003).”
BackgroundSelf-citationSignaling mechanisms of angiotensin II in regulating vascular senescence
Min, L., Mogi, M., Iwai, M., & Horiuchi, M. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.002 · Cited by 105
“Senescence is defined as a form of permanent and irreversible proliferation arrest, and displays altered gene and protein expression compared to those in a state of proliferation (Blagosklonny, 2003).”
BackgroundHyper-mitogenic drive coexists with mitotic incompetence in senescent cells
Leontieva, O. V., Lenzo, F., Demidenko, Z. N., & Blagosklonny, M. V. (2012) · Cell Cycle · doi:10.4161/cc.22937 · Cited by 90
Self-citationMEK drives cyclin D1 hyperelevation during geroconversion
Leontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.86 · Cited by 94
“Elimination of cyclin D1 by siRNA did not prevent other markers of senescence that are consistent with the lack of its effect on MTOR.”
BackgroundSelf-citationWhy men age faster but reproduce longer than women: mTOR and evolutionary perspectives
Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100149 · Cited by 88
“Cellular aging is driven by the remaining activation of mitogenic signaling pathways in post-mitotic cells [19, 20].”
Self-citationOncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence
Leikam, C., Hufnagel, A., Schartl, M., & Meierjohann, S. (2008) · Oncogene · doi:10.1038/onc.2008.323 · Cited by 94
“Most senescent cells described in the literature are blocked in G0, thereby preventing endomitosis and the appearance of multiple nuclei (Itahana et al., 2002; Blagosklonny, 2003).”
BackgroundLong-term molecular and cellular stability of human neural stem cell lines
Villa, A., Navarro‐Galve, B., Bueno, C., Franco, S., Blasco, M. A., & Martínez-Serrano, A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.025 · Cited by 91
From rapalogs to anti-aging formula
Blagosklonny, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18033 · Cited by 83
Self-citationProspective strategies to enforce selectively cell death in cancer cells
Blagosklonny, M. V. (2004) · Oncogene · doi:10.1038/sj.onc.1207520 · Cited by 94
“…of discriminating cancer and normal cells, it may be easier to exploit peculiarities of normal tissues: incorporation of iodine by thyroid or dependence on androgens, estrogens and thyroid-stimulating hormone (TSH) for prostate, breast, and thyroid tissues, respectively (Blagosklonny, 2003c).”
BackgroundInfluentialSelf-citationBonda, D. J., Evans, T. A., Santocanale, C., Llosá, J. C., Viňa, J., Bajic, V. P., Castellani, R. J., Siedlak, S. L., Perry, G., Smith, M. A., et al. (2009) · Aging · doi:10.18632/aging.100044 · Cited by 83
Demidenko, Z. N., & Blagosklonny, M. V. (2009) · Aging · doi:10.18632/aging.100115 · Cited by 81
“In theory, cellular senescence is caused by inappropriate activation of growth-promoting pathways, when actual growth is impossible [7, 8].”
BackgroundSelf-citationRapamycin extends life- and health span because it slows aging
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100591 · Cited by 81
“MTOR-driven geroconversion is a conversion from quiescence to senescence [40-59].”
BackgroundSelf-citationMühleder, S., Fernández-Chacón, M., García-Gónzalez, I., & Benedito, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03664-y · Cited by 89
Hormesis does not make sense except in the light of TOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100411 · Cited by 78
“In quiescent (resting) cells, growthpromoting pathways drive senescence [80, 81].”
BackgroundSelf-citationCell senescence, rapamycin and hyperfunction theory of aging
Blagosklonny, M. V. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2054636 · Cited by 78
“Strong growth stimulation simultaneously induces cyclins and CDK inhibitors (p21, p16), thus causing cell cycle arrest because inhibitors are dominant [7].”
BackgroundInfluentialSelf-citationOncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest
Foy, R., Crozier, L., Pareri, A. U., Valverde, J. M., Park, B. H., Ly, T., & Saurin, A. T. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.020 · Cited by 81
“The concept that hyper-mitogenic signals can drive overgrowth and senescence in arrested cells was proposed nearly 2 decades ago 45 but has received little attention since.”
BackgroundBlagosklonny, M. V. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0722 · Cited by 67
“26 33 In aging organisms, cellular hyperplasia and hypertrophy (increased cell proliferation and cell size growth, respectively) are manifest as benign tumors, cancers, atherosclerotic plaques, cardiac hypertrophy, fibrosis, and enlarged fat tissue.”
Self-citationMelanocytic nevi in pregnancy: histologic features and Ki‐67 proliferation index
Chan, M. P., Chan, M. M., & Tahan, S. R. (2009) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2009.01491.x · Cited by 66
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
Leontieva, O. V., Demidenko, Z. N., & Blagosklonny, M. V. (2015) · Oncotarget · doi:10.18632/oncotarget.4836 · Cited by 65
“When the cell cycle is forcefully arrested, but mTOR is still active (as in proliferating cells), then mTOR drives “senescence” [49, 50].”
Self-citationLawson, B. R., Baccala, R., Song, J., Croft, M., Kono, D. H., & Theofilopoulos, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031685 · Cited by 65
“Growth factors initiate and maintain the entry of cells from G1 to S phase in the cell cycle (42).”
Blagosklonny, M. V. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1818 · Cited by 76
Self-citationRapamycin, proliferation and geroconversion to senescence
Blagosklonny, M. V. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1554781 · Cited by 62
“This block cannot be reversed by growth stimulation, which only deepens the block and enhances mTOR-dependent geroconversion, but it can be reversed by inactivating p53, p21 and p16, for instance [3,15,89].”
BackgroundSelf-citationmiR-543 and miR-590-3p regulate human mesenchymal stem cell aging via direct targeting of AIMP3/p18
Lee, S., Yu, K., Ryu, Y.-S., Oh, Y. S., Hong, I., Kim, H.-S., Lee, J. Y., Kim, S., Seo, K., & Kang, K. (2014) · AGE · doi:10.1007/s11357-014-9724-2 · Cited by 61
“In addition to replicative senescence, ionizing radiation, DNA-damaging drugs such as mitomycin C, oxidative stress, and histone acetylase inhibitors can trigger premature cellular senescence (Blagosklonny 2003; Chang et al. 1999; Itahana et al. 2001; McConnell et al. 1998; Roninson et al. 2001; Terao et al. 2001).”
BackgroundThe LNT model for cancer induction is not supported by radiobiological data
Scott, B. R., & Tharmalingam, S. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.013 · Cited by 60
He, J., Zhang, A., Song, Z., Guo, S., Chen, Y., Liu, Z., Zhang, J., Xu, X., Liu, J., & Chu, L. (2019) · Bioscience Reports · doi:10.1042/bsr20190112 · Cited by 58
“Theoretical considerations indicate that mitogenic stimulation might intensify cellular senescence [48].”
RetractedChen, F., Wang, Q., Wang, X., & Studzinski, G. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0806 · Cited by 53
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51
NCI's provocative questions on cancer: some answers to ignite discussion
Blagosklonny, M. V. (2011) · Oncotarget · doi:10.18632/oncotarget.432 · Cited by 54
“This is quiescence [121, 122].”
Self-citationNrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development
Grego‐Bessa, J., Gómez-Apiñániz, P., Prados, B., Gómez, M. J., MacGrogan, D., & de la Pompa, J. L. (2023) · Circulation Research · doi:10.1161/circresaha.123.323321 · Cited by 56
“56 Two types of cell cycle arrest are highlighted here 36 : (1) classical (hypomitogenic) growth arrest caused by growth factor withdrawal, resulting in cell cycle exit characterized by inactivation of both upstream (Ras-Mapk signaling) and downstream proliferation factors; (2) hypermitogenic cell…”
BackgroundTargeting Cell Senescence for the Treatment of Age-Related Bone Loss
Pignolo, R. J., Samsonraj, R. M., Law, S. F., Wang, H., & Chandra, A. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00504-2 · Cited by 54
Chen, C.-R., Wang, W., Rogoff, H. A., Li, X., Mang, W., & Li, C. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0677 · Cited by 52
“In addition, simultaneous activation of mitogen-dependent kinases and induction of CDK inhibitors such as p21 causes cell senescence (16).”
BackgroundProgeria, rapamycin and normal aging: recent breakthrough
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100352 · Cited by 50
“But cell cycle arrest is not yet senescence [23, 19].”
BackgroundSelf-citationBig mice die young but large animals live longer
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100551 · Cited by 50
“Similarly, mice overproducing growth hormone and IGF are bigger and live shorter lives [6-70].”
BackgroundSelf-citationImmunosuppressants in cancer prevention and therapy
Blagosklonny, M. V. (2013) · OncoImmunology · doi:10.4161/onci.26961 · Cited by 48
“Cellular models of accelerated senescence have been useful to define the molecular and cellular bases of aging.(30,31) Cultured cells are generally overstimulated by growth factors, nutrientrich conditions and elevated oxygen levels.”
MethodSelf-citationJackson, T., Salmiņa, K., Huna, A., Inashkina, I., Jankevics, E., Riekstiņa, U., Kalniņa, Z., Ivanov, A., Townsend, P. A., Cragg, M. S., et al. (2013) · Cell Cycle · doi:10.4161/cc.23285 · Cited by 49
“For example, the concept of hyper-mitogenic arrest intimates that simultaneous stimulation of mitogen-activated pathways (integrated by mTOR) and downstream inhibition of cyclin-dependent kinases promotes senescence.(14) Similarly, DNA damage-induced senescence occurs in immortalized WI38 fibroblasts only when mitogen…”
BackgroundWu, D., Sun, J. K., & Chow, H. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002559 · Cited by 56
Effect of HIV-1 Vpr on Cell Cycle Regulators
Amini, S., Khalili, K., & Sawaya, B. E. (2004) · DNA and Cell Biology · doi:10.1089/104454904773819833 · Cited by 54
“Cdks are serine/threonine protein kinases that are activated at specific points in the cell cycle (Blagosklonny, 2003).”
M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/cc.27973 · Cited by 46
Self-citationUncoupling reproduction from metabolism extends chronological lifespan in yeast
Nagarajan, S., Kruckeberg, A. L., Schmidt, K. H., Kroll, E., Hamilton, M., McInnerney, K., Summers, R., Taylor, T. S., & Rosenzweig, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323918111 · Cited by 47
“We find that nondividing yeast encapsulated in a permeable matrix and fed ad libitum resembles in key respects postmitotic metazoan cells (16, 17), offering an alternative paradigm for studying mechanisms that control CLS in all eukaryotes.”
BackgroundWojda, A., Zietkiewicz, E., Mossakowska, M., Pawlowski, W., Skrzypczak, K., & Witt, M. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.8.763 · Cited by 46
“DISCUSSION Both classical and molecular cytogenetic studies suggest that cellular aging is associated with a decrease in genome stability (1,3,8,13).”
Ke, S., Lai, Y., Zhou, T., Li, L., Wang, Y., Ren, L., & Ye, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00714 · Cited by 45
Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
Mahale, S., Bharate, S. B., Manda, S., Joshi, P., Jenkins, P. R., Vishwakarma, R. A., & Chaudhuri, B. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.96 · Cited by 45
Leontieva, O. V., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026126 · Cited by 44
“Non-dividing (arrested) cells can be either quiescent or senescent [1,2].”
BackgroundSelf-citationLeukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3
Wang, Y., Gao, A., Zhao, H., Lu, P., Cheng, H., Dong, F., Gong, Y., Ma, S., Zheng, Y., Zhang, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.81 · Cited by 39
Embryonic defects and growth alteration in mice with homozygous disruption of thePatz1gene
Valentino, T., Palmieri, D., Vitiello, M., Simeone, A., Palma, G., Arra, C., Chieffi, P., Chiariotti, L., Fusco, A., & Fedele, M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24174 · Cited by 39
“It is likely that conflicting signals could account for cell cycle arrest (hypermitogenic arrest) that might then induce premature senescence (Blagosklonny, 2003).”
BackgroundAnti-aging: senolytics or gerostatics (unconventional view)
Blagosklonny, M. V. (2021) · Oncotarget · doi:10.18632/oncotarget.28049 · Cited by 40
Self-citationmiR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts
Pitto, L., Rizzo, M., Simili, M., Colligiani, D., Evangelista, M., Mercatanti, A., Mariani, L., Cremisi, F., & Rainaldi, G. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00085.2009 · Cited by 40
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Oncotarget · doi:10.18632/oncotarget.3011 · Cited by 40
“Depending on the cellular context, PMA can cause either cell cycle progression or cell cycle arrest by inducing both cyclin D1 and p21 via the MEK/ERK pathway [43, 86-88].”
BackgroundSelf-citationAging and the Biological Response to Liver Injury
Marzioni, M., Pinto, C., Ninfole, E., Gaggiano, L., Benedetti, A., & Maroni, L. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402033 · Cited by 36
Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die
Wong, M. M.-K., Joyson, S. M., Hermeking, H., & Chiu, S. K. (2021) · Cancers · doi:10.3390/cancers13040676 · Cited by 36
“Mitogens interact with receptors presented on the cell surface and activate signaling pathways related to cell proliferation, survival and death [23].”
BackgroundMicrotubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1
Tierno, M. B., Kitchens, C. A., Petrik, B., Graham, T. H., Wipf, P., Xu, F. L., Saunders, W. S., Raccor, B. S., Balachandran, R., Day, B. W., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147330 · Cited by 39
“It has been suggested that this phenomenon occurs because of hypermitogenic senescence, where supraphysiologic levels of mitogens (Ras/Raf/mitogen-activated protein kinase) increase cyclin D levels (Blagosklonny, 2003), but to date, our efforts to identify activation of the mitogen-activated protein kinase pathway hav…”
The hyperfunction theory of aging: three common misconceptions
Blagosklonny, M. V. (2021) · Oncoscience · doi:10.18632/oncoscience.545 · Cited by 47
“The arrested cells grow in size exponentially [15] (without division) and become large, flat, and hyperfunctional, namely beta Galpositive (lysosomal hyperfunction), SASP (hyper-secretory phenotype), and compensatory insulin/growth factorresistant [16, 17], as could be predicted on theoretical grounds [18].”
BackgroundSelf-citationPfeuty, B. (2015) · Development · doi:10.1242/dev.112649 · Cited by 37
“By contrast, overexpression of Cdk inhibitors (CKIs) of the Cip/Kip family resulting from the activation of diverse pathways – notably the stress and differentiation pathways – triggers irreversible cell cycle exit (Walsh and Perlman, 1997; Blagosklonny, 2003; Buttitta and Edgar, 2007).”
BackgroundIs “cellular senescence” a misnomer?
Gems, D., & Kern, C. C. (2022) · GeroScience · doi:10.1007/s11357-022-00652-x · Cited by 35
“In growth-stimulated fibroblasts, blocking the cell cycle can trigger differentiation into the hypertrophic, hypersecretory remodeling state [25].”
BackgroundRejuvenating immunity: “anti-aging drug today” eight years later
Blagosklonny, M. V. (2015) · Oncotarget · doi:10.18632/oncotarget.3740 · Cited by 34
“In 2003 it was proposed that activation of growthpromoting pathways should cause senescence, when the cell cycle is blocked [58].”
Self-citationDąbrowska, M., Skoneczny, M., & Rode, W. (2011) · Tumor Biology · doi:10.1007/s13277-011-0198-x · Cited by 38
“Cellular senescence is a stable and conditionally reversible growth arrest evoked by stress signals culminating in the induction of DNA damage response [1, 2].”
BackgroundSangrar, W., Shi, C., Mullins, G., LeBrun, D. P., Ingalls, B., & Greer, P. A. (2014) · Oncogene · doi:10.1038/onc.2014.340 · Cited by 31
Genomic Instability and Cellular Senescence: Lessons From the Budding Yeast
Lee, J. W., & Ong, E. B. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619126 · Cited by 35
“Senescent cells remain metabolically active and are viable for a long period of time (Blagosklonny, 2003), and exhibit phenotypes such as enlarged intracellular organelles and increased cell size (Cristofalo et al., 2004; Matsui and Matsuura, 2010) While aging is caused by structural deteriorations…”
BackgroundM(o)TOR of aging: MTOR as a universal molecular hypothalamus
Blagosklonny, M. V. (2013) · Aging · doi:10.18632/aging.100580 · Cited by 29
“A senescent phenotype is characterized by hyperfunction (such as a hypersecretory and pro-inflammatory phenotype) and secondary signal resistance [21, 22].”
BackgroundSelf-citationDąbrowska, M., Mosieniak, G., Skierski, J., Sikora, E., & Rode, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.015 · Cited by 34
“Senescence is also considered to result from hypermitogenic cell cycle arrest, occurring as a response to high proliferative stimulation ultimately counteracted by expression of CDK inhibitors [22].”
BackgroundOkonkwo, U. C., Ohagwu, C. C., Aronu, M. E., Okafor, C. E., Idumah, C. I., Okokpujie, I. P., Chukwu, N. N., & Chukwunyelu, C. E. (2022) · Journal of Environmental Radioactivity · doi:10.1016/j.jenvrad.2022.106984 · Cited by 31
Siriwardena, S. U., Perera, M. L. W., Senevirathne, V., Stewart, J., & Bhagwat, A. S. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00238-18 · Cited by 25
“When PMA causes cell cycle arrest, some cells arrest in G2 (59, 62), while others arrest at the G1 boundary (66) by a process referred to as hypermitogenic arrest (67).”
BackgroundCellular senescence: when growth stimulation meets cell cycle arrest
Blagosklonny, M. V. (2023) · Aging · doi:10.18632/aging.204543 · Cited by 38
“As suggested, excessive mitogen/growth-stimulation may lead to hypermitogenic arrest [32] and then full-blown cell senescence [9, 31].”
BackgroundSelf-citationBlagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.14.16819 · Cited by 28
“All these features can be explained by continuous cellular mass growth in the absence of cell division.(14) Growth-promoting pathways such as mTOR (Target of Rapamycin) drive cell growth.”
BackgroundSelf-citationRestoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells
Kobayashi, T., Nakamura, E., Shimizu, Y., Terada, N., Maeno, A., Kobori, G., Kamba, T., Kamoto, T., Ogawa, O., & Inoue, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.146 · Cited by 30
Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes
Berman, A. E., Leontieva, O. V., Natarajan, V., McCubrey, J. A., Demidenko, Z. N., & Nikiforov, M. A. (2012) · Oncotarget · doi:10.18632/oncotarget.889 · Cited by 29
“In 2003, he proposed that active growth-promoting pathways that increase cellular size must in fact cause the senescent phenotype, when the cell cycle was blocked and actual cellular growth was not possible [63-64].”
BackgroundInhibition of brain tumor cell proliferation by alternating electric fields
Jeong, H., Sung, J., Oh, S.-I., Jeong, S. H., Koh, E. K., Hong, S., & Yoon, M. (2014) · Applied Physics Letters · doi:10.1063/1.4902112 · Cited by 23
Dulić, V. (2011) · Aging · doi:10.18632/aging.100257 · Cited by 22
“This exciting but rather heretic hypothesis was based on initial observations showing that senescent phenotype requires cell growth [8, 9] and that, unlike ectopic p21 expression or DNA damage by doxorubicin, p53 induction caused quiescence instead of senescence in some cells [10].”
BackgroundPfeuty, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035291 · Cited by 25
“While S-phase entry relies on the abrupt accumulation of active cyclin E-Cdk2 complexes in the nucleus, eukaryotic cells have evolved two major mechanisms to delay and prevent G1/S transit [3]: (i) downregulation of cyclin synthesis; (ii) inhibition of the cyclin E-Cdk2 activity by association with Cdk inhibitory prot…”
BackgroundOhtsuka, S., Ogawa, S., Wakamatsu, E., & Abe, R. (2016) · International Immunology · doi:10.1093/intimm/dxw037 · Cited by 24
Badiola, I., Santaolalla, F., García-Gallastegui, P., del Rey, A. S., Unda, F. J., & Ibarretxe, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.03.004 · Cited by 24
“inally, excessive mitogenic signalling and/or overexpression of ncogenes may trigger either a cellular neoplastic transformation r alternatively cellular senescence, depending on the cell conext (Sarkisian et al., 2007; Blagosklonny, 2003).”
BackgroundSenescence-Like Phenotypes in Human Nevi
Joselow, A., Lynn, D., Terzian, T., & Box, N. F. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_17 · Cited by 29
Iwamoto, N., D’Alessandro, L. A., Depner, S., Hahn, B., Kramer, B. A., Lucarelli, P., Vlasov, A., Stepath, M., Böhm, M. E., Deharde, D., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab1967 · Cited by 22
Metadata
- Authors
- Blagosklonny, M. V.
- Affiliations
- New York Medical College (US)
- Corresponding author
- Blagosklonny, Mikhail V
- Venue
- The EMBO Reports
- Published
- 2003-04-01
- Volume
- 4
- Issue
- 4
- Pages
- 358-362
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1319162
- OpenAlex
- W2038880350
- Cited by
- 156
- References
- 64
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 7 · 2014: 12 · 2013: 9 · 2012: 11
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, mitogen stimulation, cyclin-dependent kinases, growth arrest, apoptosis, cytotoxic stress
- MeSH terms
- Animals, Cell Cycle, Cell Division, Mitosis, Signal Transduction, Cellular Senescence, Cyclin-Dependent Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.